spendergast captains blog

Health Care Systems Oncology, Imaging and Pharmacology, particularly for Prostate Cancer. Technology that interests me: Sensors (Radar, Sonar, EO/IR,Fusion) Communications, Satellites, Unmanned Vehicles (UAV), Information Technology, Intelligent Transportation

Monday, August 31, 2020

Surgery Rates Doubled for High-Risk Prostate Cancer | MedPage Today

Surgery Rates Doubled for High-Risk Prostate Cancer | MedPage Today
Stephen Pendergast at 1:12 PM No comments:

Meeting report from the prostate cancer foundation PSMA theranostics state of the science meeting - Miyahira - - The Prostate - Wiley Online Library

Meeting report from the prostate cancer foundation PSMA theranostics state of the science meeting - Miyahira - - The Prostate - Wiley Online Library
Stephen Pendergast at 8:35 AM No comments:

Sunday, August 30, 2020

Mitoxantrone and Veliparib in Prostate Cancer: Updates from ASCO 2017 - YouTube

Mitoxantrone and Veliparib in Prostate Cancer: Updates from ASCO 2017 - YouTube
Stephen Pendergast at 5:59 PM No comments:

Risk calculators for men already on active surveillance | THE "NEW" PROSTATE CANCER INFOLINK

Risk calculators for men already on active surveillance | THE "NEW" PROSTATE CANCER INFOLINK
Stephen Pendergast at 9:02 AM No comments:

Protecting Your Bones and Improving Your Quality of Life During Prostate Cancer Treatment — Cancer ABCs

Protecting Your Bones and Improving Your Quality of Life During Prostate Cancer Treatment — Cancer ABCs
Stephen Pendergast at 9:01 AM No comments:

Friday, August 28, 2020

Abiraterone and enzalutamide had different adverse effects on the cardiovascular system: a systematic review with pairwise and network meta-analyses | Prostate Cancer and Prostatic Diseases

Abiraterone and enzalutamide had different adverse effects on the cardiovascular system: a systematic review with pairwise and network meta-analyses | Prostate Cancer and Prostatic Diseases
Stephen Pendergast at 6:29 PM No comments:

Prostatepedia Digest 8.28.2020

Prostatepedia Digest 8.28.2020
Stephen Pendergast at 8:48 AM No comments:

Thursday, August 27, 2020

Prostate Cancer Treatment Protocols: Treatment Protocols

Prostate Cancer Treatment Protocols: Treatment Protocols
Stephen Pendergast at 6:07 PM No comments:

Prostate Cancer Staging: TNM Classification for Prostate Cancer

Prostate Cancer Staging: TNM Classification for Prostate Cancer
Stephen Pendergast at 5:56 PM No comments:

Deep-Learning Algorithm Grades Prostate Cancer Biopsy Specimens

Deep-Learning Algorithm Grades Prostate Cancer Biopsy Specimens
Stephen Pendergast at 3:04 PM No comments:

Optimizing the management of castration‐resistant prostate cancer patients: A practical guide for clinicians

onlinelibrary.wiley.com/doi/abs/10.1002/pros.24066?af=R
Stephen Pendergast at 9:34 AM No comments:

Wednesday, August 26, 2020

Who actually dies from prostate cancer? Additional observations | THE "NEW" PROSTATE CANCER INFOLINK

Who actually dies from prostate cancer? Additional observations | THE "NEW" PROSTATE CANCER INFOLINK
Stephen Pendergast at 12:45 PM No comments:

Dr. Trinh on How COVID-19 Has Impacted Surgical Decisions in Prostate Cancer - YouTube

Dr. Trinh on How COVID-19 Has Impacted Surgical Decisions in Prostate Cancer - YouTube
Stephen Pendergast at 9:59 AM No comments:

Circulating Tumor DNA in Metastatic Prostate Cancer - YouTube

Circulating Tumor DNA in Metastatic Prostate Cancer - YouTube
Stephen Pendergast at 9:58 AM No comments:

Who actually dies from prostate cancer? | THE "NEW" PROSTATE CANCER INFOLINK

Who actually dies from prostate cancer? | THE "NEW" PROSTATE CANCER INFOLINK
Stephen Pendergast at 9:14 AM No comments:

Monday, August 24, 2020

Genetic Risk Score for Prostate Cancer Screening - YouTube

Genetic Risk Score for Prostate Cancer Screening - YouTube
Stephen Pendergast at 5:48 PM No comments:

Sunday, August 23, 2020

Synergy between radiation of metastases and immunotherapy confirmed | THE "NEW" PROSTATE CANCER INFOLINK

Synergy between radiation of metastases and immunotherapy confirmed | THE "NEW" PROSTATE CANCER INFOLINK
Stephen Pendergast at 8:51 AM No comments:

Saturday, August 22, 2020

Diagnostic ability of Ga-68 PSMA PET to detect dominant and non-dominant tumors, upgrading and adverse pathology in patients with PIRADS 4–5 index lesions undergoing radical prostatectomy | Prostate Cancer and Prostatic Diseases

Diagnostic ability of Ga-68 PSMA PET to detect dominant and non-dominant tumors, upgrading and adverse pathology in patients with PIRADS 4–5 index lesions undergoing radical prostatectomy | Prostate Cancer and Prostatic Diseases
Stephen Pendergast at 3:18 PM No comments:

Friday, August 21, 2020

Dosing Begins in Trial of PET Imaging Agent for Prostate Cancer's Return

Dosing Begins in Trial of PET Imaging Agent for Prostate Cancer's Return
Stephen Pendergast at 4:06 PM No comments:

Prostatepedia Digest 8.21.2020

 Prostatepedia Digest 8.21.2020

Stephen Pendergast at 4:05 PM No comments:

Diagnostic ability of Ga-68 PSMA PET to detect dominant and non-dominant tumors, upgrading and adverse pathology in patients with PIRADS 4–5 index lesions undergoing radical prostatectomy | Prostate Cancer and Prostatic Diseases

Diagnostic ability of Ga-68 PSMA PET to detect dominant and non-dominant tumors, upgrading and adverse pathology in patients with PIRADS 4–5 index lesions undergoing radical prostatectomy | Prostate Cancer and Prostatic Diseases
Stephen Pendergast at 9:02 AM No comments:

Thursday, August 20, 2020

Hormonal treatments for prostate cancer are often given late - Harvard Health Blog - Harvard Health Publishing

Hormonal treatments for prostate cancer are often given late - Harvard Health Blog - Harvard Health Publishing
Stephen Pendergast at 10:33 AM No comments:

Wednesday, August 19, 2020

Quantifying observational evidence for risk of dementia following androgen deprivation therapy for prostate cancer: an updated systematic review and meta-analysis | Prostate Cancer and Prostatic Diseases

Quantifying observational evidence for risk of dementia following androgen deprivation therapy for prostate cancer: an updated systematic review and meta-analysis | Prostate Cancer and Prostatic Diseases
Stephen Pendergast at 1:16 PM No comments:

Treatment of metastatic castration resistant prostate cancer with radium-223: a retrospective study at a US tertiary oncology center | Prostate Cancer and Prostatic Diseases

Treatment of metastatic castration resistant prostate cancer with radium-223: a retrospective study at a US tertiary oncology center | Prostate Cancer and Prostatic Diseases
Stephen Pendergast at 1:15 PM No comments:

Xconomy: Patient Death in Poseida Prostate Cancer Study Prompts Clinical Hold

Xconomy: Patient Death in Poseida Prostate Cancer Study Prompts Clinical Hold
Stephen Pendergast at 8:47 AM No comments:

Monday, August 17, 2020

Improving Specificity of PSA Screening w/ Serum & Urine Markers: Who Doesn’t Need a Prostate Biopsy? - YouTube

Improving Specificity of PSA Screening w/ Serum & Urine Markers: Who Doesn’t Need a Prostate Biopsy? - YouTube
Stephen Pendergast at 8:30 AM No comments:

Radium-223 in Metastatic CRPC - YouTube

Radium-223 in Metastatic CRPC - YouTube
Stephen Pendergast at 8:30 AM No comments:

Emerging Therapies for Advanced Prostate Cancer - YouTube

Emerging Therapies for Advanced Prostate Cancer - YouTube
Stephen Pendergast at 8:29 AM No comments:

Sunday, August 16, 2020

Prostate Theranostics - What the Hell? — Cancer ABCs

Prostate Theranostics - What the Hell? — Cancer ABCs
Stephen Pendergast at 12:01 PM No comments:

Saturday, August 15, 2020

miR Sentinel tests 90+ percent accurate in diagnosis of prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK

miR Sentinel tests 90+ percent accurate in diagnosis of prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK
Stephen Pendergast at 9:21 AM No comments:

miR Sentinel tests 90+ percent accurate in diagnosis of prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK

miR Sentinel tests 90+ percent accurate in diagnosis of prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK
Stephen Pendergast at 9:21 AM No comments:

Friday, August 14, 2020

Surgical vs Intermittent Castration for Prostate Cancer - YouTube

Surgical vs Intermittent Castration for Prostate Cancer - YouTube
Stephen Pendergast at 3:23 PM No comments:

Lower COVID-19 Risk With ADT for Prostate Cancer | MedPage Today

Lower COVID-19 Risk With ADT for Prostate Cancer | MedPage Today
Stephen Pendergast at 3:22 PM No comments:

Prostatepedia Digest 8.14.2020

Prostatepedia Digest 8.14.2020
Stephen Pendergast at 1:26 PM No comments:

Thursday, August 13, 2020

Prostate Cancer Debate: Treatment strategies and options in castration-resistant prostate cancer - YouTube

Prostate Cancer Debate: Treatment strategies and options in castration-resistant prostate cancer - YouTube
Stephen Pendergast at 9:57 AM No comments:

Wednesday, August 12, 2020

Optimizing the management of castration‐resistant prostate cancer patients: A practical guide for clinicians - Shore - - The Prostate - Wiley Online Library

Optimizing the management of castration‐resistant prostate cancer patients: A practical guide for clinicians - Shore - - The Prostate - Wiley Online Library
Stephen Pendergast at 9:02 AM No comments:

The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs | Nature Reviews Urology

The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs | Nature Reviews Urology
Stephen Pendergast at 9:01 AM No comments:

Friday, August 7, 2020

Neoadjuvant CHT + surgery for men with high-risk, localized prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK

Neoadjuvant CHT + surgery for men with high-risk, localized prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK
Stephen Pendergast at 5:50 PM 1 comment:

Prostatepedia Digest 8.7.2020

Prostatepedia Digest 8.7.2020
Stephen Pendergast at 5:47 PM No comments:

Beyond PSA: New Prostate Cancer Screening Options

Beyond PSA: New Prostate Cancer Screening Options
Stephen Pendergast at 5:46 PM No comments:

A Call to Test Men With Prostate Cancer for COVID-19

A Call to Test Men With Prostate Cancer for COVID-19
Stephen Pendergast at 5:45 PM No comments:

PSA doubling time and prognosis for men with nmCRPC | THE "NEW" PROSTATE CANCER INFOLINK

PSA doubling time and prognosis for men with nmCRPC | THE "NEW" PROSTATE CANCER INFOLINK
Stephen Pendergast at 5:43 PM No comments:

Monday, August 3, 2020

Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study

Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study
Stephen Pendergast at 12:23 PM No comments:
‹
›
Home
View web version

About Me

My photo
Stephen Pendergast
View my complete profile
Powered by Blogger.